Jupiter Neurosciences
JUNS
9 hedge funds and large institutions have $2.39M invested in Jupiter Neurosciences in 2025 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 0 closing their positions.
3,508% more capital invested
Capital invested by funds: $66.3K → $2.39M (+$2.33M)
350% more funds holding
Funds holding: 2 → 9 (+7)
0.05% more ownership
Funds ownership: 0% → 0.05% (+0.05%)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VC
Vestor Capital
Chicago,
Illinois
|
+$1.47M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$327K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$157K |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$37.7K |
| 5 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$22.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$75.5K |
JUNS Hedge Fund Activity: Q3 2025 in Review
9 of the 7,640 institutional investors tracked by Wall St. Rank reported a position in Jupiter Neurosciences (JUNS) for Q3 2025, worth a combined $2.39M — up 3,508% from $66.3K a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new JUNS positions and 0 closed out — a net gain of 7 holders — while 1 added to existing stakes and 1 trimmed.
The largest buyer was Vestor Capital, opening a new position worth an estimated $1.47M. The largest seller was UBS Group, cutting an estimated $75.5K.
- 9 institutional investors held Jupiter Neurosciences (JUNS) as of Q3 2025, up from 2 in Q2 2025.
- Funds reported $2.39M of Jupiter Neurosciences stock for Q3 2025, up 3,508% quarter-over-quarter.
- 7 funds opened new Jupiter Neurosciences positions in Q3 2025 and 0 closed out, a net change of +7 holders.
- The largest Jupiter Neurosciences buyer in Q3 2025 was Vestor Capital, an estimated $1.47M added.
- The largest Jupiter Neurosciences seller in Q3 2025 was UBS Group, an estimated $75.5K sold.
Based on aggregated 13F filings for Q3 2025.